• Radicicol: Hsp90 Inhibitor for Adipogenesis & Apoptosis Assa

  2026-05-26

  Radicicol stands apart as a potent Hsp90 inhibitor, enabling researchers to dissect adipocyte differentiation, apoptosis, and inflammation pathways with precision. This article translates the latest workflow innovations and troubleshooting strategies into actionable protocols for maximizing Radicicol's impact in translational research.

• Advancing β2-Adrenergic Binding Studies via Part-Coated CEC

  2026-05-26

  This study introduces an innovative open-tubular capillary electrochromatography (CEC) technique using part-coating columns to determine binding constants between β2-adrenergic receptors and multiple drugs. The method reduces protein consumption, yields reliable affinity data, and offers broad utility for adrenergic receptor and drug interaction research.

• Captopril Beyond Hypertension: Mechanisms and Assay Precisio

  2026-05-25

  Explore Captopril's unique role as an ACE inhibitor in both hypertension and cancer research. This article provides advanced mechanistic insights and practical assay guidance, offering a distinct perspective for those seeking scientific depth.

• Liproxstatin-1 HCl in Ferroptosis Assays: Protocols & Pitfal

  2026-05-25

  Liproxstatin-1 HCl empowers researchers to dissect ferroptosis with nanomolar precision and robust selectivity, making it a gold-standard tool in acute renal failure and hepatic ischemia workflows. This guide distills latest mechanistic insights, scalable protocols, and advanced troubleshooting strategies to maximize reproducibility and reliability in applied ferroptosis research.

• Arctigenin as a KEAP1-NRF2 Inhibitor Mitigates Doxorubicin C

  2026-05-24

  This study identifies arctigenin, via high-throughput screening, as a novel natural inhibitor of the KEAP1-NRF2 protein-protein interaction, which protects against doxorubicin-induced cardiotoxicity in vitro and in vivo. Mechanistic insights reveal that arctigenin binds KEAP1 at Ser602, enhancing NRF2 signaling and reducing oxidative stress, ferroptosis, and mitochondrial dysfunction—implicating potential translational value for developing adjunctive cardioprotective therapies.

• Triiodothyronine (T3) in Advanced Metabolic Assays

  2026-05-23

  Triiodothyronine (T3) empowers precision in thyroid hormone signaling pathway studies, driving breakthroughs in adipocyte differentiation and metabolic regulation. APExBIO’s high-purity T3 ensures robust, reproducible results in cellular and biochemical research, even in challenging thermogenesis and gene expression assays.

• iPSC-Derived Organoids Enable Multilineage HEV Modeling In V

  2026-05-22

  The referenced study establishes iPSC-derived human liver, intestinal, and brain organoids as robust models for propagating multiple hepatitis E virus (HEV) genotypes. This innovation provides a physiologically relevant platform for studying HEV pathogenesis and antiviral strategies, with implications for translational infectious disease research beyond traditional cell lines.

• Metabolite Regulation of TET2: Protocols for Enzyme Activity

  2026-05-22

  The reference study introduces a robust protocol combining biochemical assays and STD NMR spectroscopy to validate metabolite binding and regulatory effects on TET2 dioxygenase. This framework advances our understanding of how metabolic states influence epigenetic enzyme activity, with broad implications for cancer and metabolic research.

• BMS 599626 Dihydrochloride: Advancing EGFR/ErbB2 Inhibition

  2026-05-21

  Explore mechanistic insights and translational strategies for leveraging BMS 599626 dihydrochloride, a potent EGFR and ErbB2 inhibitor, in cancer and senescence research. This thought-leadership article bridges foundational oncogenic signaling science, robust experimental protocols, and strategic guidance for integrating APExBIO’s inhibitor into next-generation workflows, including AI-driven senolytic discovery.

• ABT-263 (Navitoclax): Practical Guidance for Apoptosis Assay

  2026-05-21

  ABT-263 (Navitoclax) is a potent, orally bioavailable Bcl-2 family inhibitor widely used to dissect caspase-dependent apoptosis in cancer biology research. It is optimal for in vitro and in vivo studies of Bcl-2, Bcl-xL, and Bcl-w-mediated survival pathways, but is not suitable for diagnostic or therapeutic applications. Correct solubilization and storage are essential for experimental reliability.

• Sulforaphane Mitigates PM2.5-Induced COPD via Nrf2 and EGFR/

  2026-05-20

  This study elucidates how sulforaphane (SFN) attenuates PM2.5-induced chronic obstructive pulmonary disease (COPD) by modulating Nrf2 activation and suppressing EGFR/PI3K/AKT signaling. The findings provide mechanistic insights into SFN's antioxidative and anti-inflammatory actions in environmentally triggered COPD, highlighting methodological advances for oxidative stress measurement in preclinical research.

• Cationic Lipid-Enriched LNPs Enhance Local mRNA Expression I

  2026-05-20

  This study systematically investigates how incorporating cationic lipids, particularly DOTAP, into lipid nanoparticle (LNP) formulations alters the biodistribution and immunogenicity of mRNA vaccines delivered intramuscularly. The findings reveal that modest DOTAP enrichment increases local protein expression and early IgG responses, offering insight into optimizing LNP design for targeted mRNA delivery.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-05-19

  This study presents an optimized protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs), overcoming key limitations of existing in vitro models for pharmacokinetic research. The work enables more reliable assessment of drug metabolism and absorption, with direct implications for drug discovery and β-adrenergic modulation studies.

• HyperScribe T7 High Yield RNA Synthesis Kit: Workflow & CRIS

  2026-05-19

  Unlock rapid, high-yield RNA synthesis for demanding applications such as CRISPR gene editing and RNA therapeutics with the HyperScribe T7 High Yield RNA Synthesis Kit. Discover protocol insights, troubleshooting strategies, and lessons from cutting-edge breast cancer research to maximize RNA quality and experimental efficiency.

• 10 mM dNTP Mixture: Precision and Trafficking in DNA Synthes

  2026-05-18

  Explore how the 10 mM dNTP mixture enables high-fidelity DNA synthesis and impacts intracellular nucleotide delivery. This article provides a unique perspective by integrating core biochemical parameters with new insights from lipid nanoparticle trafficking research.

554 records 17/37 page Previous Next First page 上5页 1617181920 下5页 Last page